Thornton Bruce has filed 3 insider transactions across 1 company since June 2024.
Most recent transaction: a grant/award of 13500 shares of Sonoma Pharmaceuticals, Inc. ($SNOA) on June 19, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 19, 2025 | Sonoma Pharmaceuticals, Inc. | $SNOA | Thornton Bruce | Executive VP and COO | A | Restricted Stock Units | 13500 | $0.00 | 32,191.0000 | 1,634,265 | 72.23% | 0.83% |
| Jan. 2, 2025 | Sonoma Pharmaceuticals, Inc. | $SNOA | Thornton Bruce | Executive VP & COO | A | Restricted Stock Units | 10000 | $0.00 | 18,691.0000 | 1,058,447 | 115.06% | 0.94% |
| June 20, 2024 | Sonoma Pharmaceuticals, Inc. | $SNOA | Thornton Bruce | Executive Vice President | A | Common Stock, $0.0001 par value | 53586 | $0.00 | 154,411.0000 | 780,371 | 53.15% | 6.87% |